George Elston - Net Worth and Insider Trading
George Elston Net Worth
The estimated net worth of George Elston is at least $56,140 dollars as of 2024-05-27. George Elston is the CFO of EyePoint Pharmaceuticals Inc and owns about 4,000 shares of EyePoint Pharmaceuticals Inc (EYPT) stock worth over $44,640. George Elston is also the CFO of Juniper Pharmaceuticals Inc and owns about 1,000 shares of Juniper Pharmaceuticals Inc (JNP) stock worth over $11,500. Details can be seen in George Elston's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that George Elston has not made any transactions after 2020-09-04 and currently still holds the listed stock(s).
Transaction Summary of George Elston
George Elston Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, George Elston owns 3 companies in total, including EyePoint Pharmaceuticals Inc (EYPT) , Juniper Pharmaceuticals Inc (JNP) , and Celldex Therapeutics Inc (CLDX) .
Click here to see the complete history of George Elston’s form 4 insider trades.
Insider Ownership Summary of George Elston
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals Inc | 2020-09-04 | Chief Financial Officer |
| JNP | Juniper Pharmaceuticals Inc | 2016-08-31 | Chief Financial Officer |
| CLDX | Celldex Therapeutics Inc | 2008-03-07 | director |
George Elston Latest Holdings Summary
George Elston currently owns a total of 2 stocks. Among these stocks, George Elston owns 4,000 shares of EyePoint Pharmaceuticals Inc (EYPT) as of September 4, 2020, with a value of $44,640 and a weighting of 79.52%. George Elston also owns 1,000 shares of Juniper Pharmaceuticals Inc (JNP) as of August 31, 2016, with a value of $11,500 and a weighting of 20.48%.
Latest Holdings of George Elston
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals Inc | 2020-09-04 | 4,000 | 11.16 | 44,640 |
| JNP | Juniper Pharmaceuticals Inc | 2016-08-31 | 1,000 | 11.50 | 11,500 |
Holding Weightings of George Elston
George Elston Form 4 Trading Tracker
According to the SEC Form 4 filings, George Elston has made a total of 4 transactions in EyePoint Pharmaceuticals Inc (EYPT) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in EyePoint Pharmaceuticals Inc is the acquisition of 1,000 shares on September 4, 2020, which cost George Elston around $4,800.
According to the SEC Form 4 filings, George Elston has made a total of 0 transactions in Juniper Pharmaceuticals Inc (JNP) over the past 5 years. The most-recent trade in Juniper Pharmaceuticals Inc is the acquisition of 1,000 shares on August 31, 2016, which cost George Elston around $5,500.
Insider Trading History of George Elston
- 1
George Elston Trading Performance
GuruFocus tracks the stock performance after each of George Elston's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by George Elston is -2.13%. GuruFocus also compares George Elston's trading performance to market benchmark return within the same time period. The performance of stocks bought by George Elston within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how George Elston's insider trading performs compared to the benchmark.
Performance of George Elston
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.88 | | | | | |
| Relative Return to S&P 500(%) | -4.12 | | | | | |
George Elston Ownership Network
George Elston Owned Company Details
What does EyePoint Pharmaceuticals Inc do?
Who are the key executives at EyePoint Pharmaceuticals Inc?
George Elston is the Chief Financial Officer of EyePoint Pharmaceuticals Inc. Other key executives at EyePoint Pharmaceuticals Inc include SVP & Chief Commercial Officer David Scott Jones , Chief Medical Officer Dario A. Paggiarino , and director & President and CEO Nancy Lurker .
EyePoint Pharmaceuticals Inc (EYPT) Insider Trades Summary
Over the past 18 months, George Elston made no insider transaction in EyePoint Pharmaceuticals Inc (EYPT). Other recent insider transactions involving EyePoint Pharmaceuticals Inc (EYPT) include a net sale of 943,936 shares made by Ew Healthcare Partners, L.p. , a net sale of 121,307 shares made by Dario A. Paggiarino , and a net purchase of 4,794,057 shares made by Cormorant Asset Management, Lp .
In summary, during the past 3 months, insiders sold 11,625 shares of EyePoint Pharmaceuticals Inc (EYPT) in total and bought 1,431,765 shares, with a net purchase of 1,420,140 shares. During the past 18 months, 4,206,561 shares of EyePoint Pharmaceuticals Inc (EYPT) were sold and 4,794,057 shares were bought by its insiders, resulting in a net purchase of 587,496 shares.
EyePoint Pharmaceuticals Inc (EYPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
EyePoint Pharmaceuticals Inc Insider Transactions
George Elston Mailing Address
Above is the net worth, insider trading, and ownership report for George Elston. You might contact George Elston via mailing address: 124 Chatham Street, Chatham Nj 07928.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
